Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development

Area of Science:

• Molecular Biology
• Cancer Research
• Developmental Biology

Background:

• Nucleophosmin (NPM1) is a protein with dual oncogenic and tumor suppressor roles.
• NPM1 gene mutations are common in acute myeloid leukemia (AML), leading to a mutant NPMc+ protein.
• The precise mechanism by which NPMc+ drives AML remains unclear.

Purpose of the Study:

• To investigate the role of NPMc+ in activating signaling pathways during early development.
• To elucidate the mechanism of NPMc+ in the pathogenesis of NPM1-mutated AML.
• To explore the relationship between NPMc+ and Wnt signaling in AML.

Main Methods:

• Utilized zebrafish as a model organism to study early developmental effects.
• Investigated the activation of canonical Wnt signaling by NPMc+.
• Analyzed Wnt pathway activity in AML patient cells and cell lines.
• Depleted NPMc+ in OCI-AML3 cells to assess its impact on Wnt target genes and beta-catenin.

Main Results:

• NPMc+ was found to activate canonical Wnt signaling during early zebrafish development.
• This activation led to an increased number of progenitor cells in primitive hematopoiesis.
• Canonical Wnt pathway activation was observed in AML blasts with NPMc+.
• NPMc+ depletion in OCI-AML3 cells reduced active beta-catenin and Wnt target gene levels.

Conclusions:

• NPMc+ plays a novel role in activating canonical Wnt signaling.
• This activation contributes to increased progenitor cell numbers, relevant to AML development.
• The findings provide new insights into the molecular mechanisms underlying NPM1-mutated AML.